data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
NeuroMetrix
(NASDAQ:NURO)
$1.56
-0.05[-3.11%]
Last update: 2:07PM (Delayed 15-Minutes)
Get Real Time Here
Day Range1.53 - 1.5852 Wk Range1.35 - 7.41Open / Close1.57 / -Float / Outstanding7.7M / 7.8M
Vol / Avg.21K / 531.9KMkt Cap12.1MP/E-50d Avg. Price2.17
Div / Yield-Payout Ratio-Total Float7.7MEPS-0.23

NeuroMetrix Stock (NASDAQ:NURO), Quotes and News Summary

NeuroMetrix Stock (NASDAQ: NURO) stock price, news, charts, stock research, profile.

Day Range1.53 - 1.5852 Wk Range1.35 - 7.41Open / Close1.57 / -Float / Outstanding7.7M / 7.8M
Vol / Avg.21K / 531.9KMkt Cap12.1MP/E-50d Avg. Price2.17
Div / Yield-Payout Ratio-Total Float7.7MEPS-0.23
Shashank Jacob -
Christopher Sappo - May 20, 2022, 11:05AM
Globe Newswire - Nov 8, 2022, 9:00AM
Globe Newswire - Nov 3, 2022, 9:00AM
Globe Newswire - Oct 20, 2022, 7:00AM
Globe Newswire - Oct 12, 2022, 3:47PM
Globe Newswire - Sep 1, 2022, 9:00AM
Globe Newswire - Jul 21, 2022, 7:00AM
Globe Newswire - Jul 14, 2022, 11:32AM
Globe Newswire - Jun 28, 2022, 9:00AM
PRNewswire - May 19, 2022, 10:55AM
Globe Newswire - May 19, 2022, 9:00AM
Globe Newswire - Apr 26, 2022, 7:00AM
Globe Newswire - Apr 19, 2022, 9:00AM
Globe Newswire - Feb 24, 2022, 9:00AM
Globe Newswire - Jan 27, 2022, 7:00AM
Globe Newswire - Jan 20, 2022, 12:10PM
PRNewswire - Jan 18, 2022, 10:55AM
Globe Newswire - Jan 18, 2022, 9:00AM
Globe Newswire - Jan 10, 2022, 9:00AM
Globe Newswire - Jan 5, 2022, 9:00AM
InvestorsObserver - 8 hours ago
InvestorsObserver - 8 hours ago
InvestorsObserver - Nov 15, 2022, 6:33AM
InvestorsObserver - Nov 10, 2022, 1:51PM
InvestorsObserver - Nov 3, 2022, 11:16AM
InvestorsObserver - Nov 1, 2022, 10:13AM
InvestorsObserver - Oct 20, 2022, 11:15AM
Seeking Alpha - Oct 20, 2022, 9:32AM
InvestorsObserver - Oct 17, 2022, 1:29PM
InvestorsObserver - Oct 13, 2022, 2:02PM
Seeking Alpha - Oct 13, 2022, 9:03AM
InvestorsObserver - Oct 12, 2022, 10:41AM
InvestorsObserver - Oct 11, 2022, 2:23PM
InvestorsObserver - Oct 11, 2022, 10:48AM
Seeking Alpha - Oct 11, 2022, 8:39AM
InvestorsObserver - Oct 10, 2022, 6:41AM
Seeking Alpha - Sep 23, 2022, 10:13AM
InvestorsObserver - Sep 14, 2022, 1:49PM
InvestorsObserver - Sep 14, 2022, 1:45PM
InvestorsObserver - Aug 4, 2022, 1:21PM
InvestorsObserver - Aug 3, 2022, 3:30PM
InvestorsObserver - Jul 28, 2022, 2:30PM
Seeking Alpha - Jul 21, 2022, 11:16AM
Seeking Alpha - Jul 21, 2022, 11:14AM
InvestorsObserver - Jun 21, 2022, 10:40AM
InvestorsObserver - Jun 17, 2022, 1:06PM
InvestorsObserver - Jun 1, 2022, 10:49AM
InvestorsObserver - May 26, 2022, 11:18AM
InvestorsObserver - May 23, 2022, 7:01AM
InvestorsObserver - May 20, 2022, 2:21PM
InvestorPlace - May 19, 2022, 2:39PM
InvestorsObserver - May 19, 2022, 10:01AM
Seeking Alpha - May 19, 2022, 9:21AM
InvestorsObserver - Apr 27, 2022, 6:55AM
Sector: Health Care.Industry: Health Care Equipment & Supplies
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment of being Medical equipment and consumables.
Read More

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-01-26
REV
Q3 2022Est.ActualSurprise
EPS-0.230
REV1.968M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy NeuroMetrix (NURO) stock?

A

You can purchase shares of NeuroMetrix (NASDAQ: NURO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are NeuroMetrix's (NURO) competitors?

Q

What is the target price for NeuroMetrix (NURO) stock?

A

The latest price target for NeuroMetrix (NASDAQ: NURO) was reported by Rodman & Renshaw on Tuesday, June 28, 2016. The analyst firm set a price target for 4.50 expecting NURO to rise to within 12 months (a possible 188.46% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for NeuroMetrix (NURO)?

A

The stock price for NeuroMetrix (NASDAQ: NURO) is $1.56 last updated Today at November 28, 2022, 7:07 PM UTC.

Q

Does NeuroMetrix (NURO) pay a dividend?

A

There are no upcoming dividends for NeuroMetrix.

Q

When is NeuroMetrix (NASDAQ:NURO) reporting earnings?

A

NeuroMetrix’s Q4 earnings are confirmed for Thursday, January 26, 2023.

Q

Is NeuroMetrix (NURO) going to split?

A

There is no upcoming split for NeuroMetrix.

Q

What sector and industry does NeuroMetrix (NURO) operate in?

A

NeuroMetrix is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.